Antifungal activity and biocompatibility assessment with molecular docking and dynamic simulations of new pyrazole derivatives

Table 10 HFB4 normal human skin cell line viability affected by various concentrations of pyrazole 3b

ID	µg/ml	O.D			Mean O.D	±SE	Viability %	Toxicity %	IC₅₀ ± SD
HFB4	——–	0.568	0.561	0.566	0.565000	0.002082	100	0	µg/ml
3b	1000	0.569	0.560	0.560	0.563000	0.003000	99.23303835	0.766961652	—–
	500	0.565	0.566	0.562	0.564333	0.001202	99.64601770	0.353982301
	250	0.564	0.567	0.562	0.564333	0.001453	99.76401180	0.235988201
	125	0.563	0.567	0.561	0.563667	0.001764	99.88200590	0.117994100
	62.5	0.561	0.567	0.564	0.564000	0.001732	99.82300885	0.117994100
	31.25	0.558	0.564	0.560	0.560667	0.001764	99.88200590	0.176991150

ISSN: 1472-6750